Ta-Sen Yeh
Overview
Explore the profile of Ta-Sen Yeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
248
Citations
3639
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsu J, Lin Y, Chen Y, Kou H, Wang S, Chou W, et al.
Biomed J
. 2024 Nov;
:100817.
PMID: 39566657
Despite advancements in medical care, surgical technologies, and the development of novel treatments over the past decade, the prognosis for patients with gastric cancer (GC) has only modestly improved. This...
2.
Tsai C, Tai T, Huang S, Chen T, Hsu J, Yeh C, et al.
Oncologist
. 2024 Nov;
PMID: 39552563
Background: Microsatellite instable (MSI) gastric cancers exhibit reduced lymph node (LN) metastasis and improved survival compared to microsatellite stable (MSS) counterparts. However, to our longstanding observation, clinical N-staging (cN) is...
3.
Huang W, Hung Y, Tsai C, Wu C, Chou W, Hsu J, et al.
Am J Cancer Res
. 2024 Aug;
14(7):3523-3532.
PMID: 39113858
Various first-line gemcitabine-based or fluorouracil-based combination regimens were approved in patients with advanced pancreatic cancer. Recent randomized clinical trials (RCTs) have investigated chemotherapy backbones in combination with novel investigational drugs,...
4.
Wu M, Chan Y, Chen M, Hung Y, Kou H, Tsai C, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064190
: For patients with obstructive jaundice and who are indicated for pancreaticoduodenectomy (PD) or biliary intervention, either endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic cholangiography and drainage (PTCD) may be...
5.
Tsai H, Shan Y, Yang C, Hsiao C, Tsai C, Wang C, et al.
BMC Cancer
. 2024 Jul;
24(1):828.
PMID: 38992597
Background: Most gastrointestinal stromal tumors (GISTs) harbor c-KIT or PDGFRA mutations. Administration of tyrosine kinase inhibitors (TKIs) has significantly improved the survival of patients with GISTs. We aimed to evaluate...
6.
Kang Y, Terashima M, Kim Y, Boku N, Chung H, Chen J, et al.
Lancet Gastroenterol Hepatol
. 2024 Jun;
9(8):705-717.
PMID: 38906161
Background: In Asia, adjuvant chemotherapy after gastrectomy with D2 or more extensive lymph-node dissection is standard treatment for people with pathological stage III gastric or gastro-oesophageal junction (GEJ) cancer. We...
7.
Huang S, Yi-Feng Chang I, Chen T, Lin H, Tsai C, Hsu J, et al.
Asian J Surg
. 2024 Jun;
47(11):4699-4705.
PMID: 38845323
Background: Numerous studies have demonstrated a correlation between p53 overexpression and diminished survival in gastric cancer patients. However, conflicting findings exist, and we hypothesize that these discrepancies arise from the...
8.
Lai C, Lee C, Yeh T, Chang M, Lin Y, Chen T
J Cancer
. 2024 May;
15(11):3313-3320.
PMID: 38817866
The study aims to evaluate the efficacy of peripheral blood inflammatory markers as clinical predictors for gastric intestinal metaplasia (IM), a known precursor to gastric cancer. This research investigates the...
9.
Chen T, Kuo C, Lee C, Yeh T, Lan J, Huang S
J Cancer
. 2024 May;
15(10):3085-3094.
PMID: 38706899
Endoscopic submucosal dissection (ESD) is a widely accepted treatment for patients with mucosa (T1a) disease without lymph node metastasis. However, the inconsistency of inspection quality of tumor staging under the...
10.
Lai Y, Lin G, Ho K, Lu K, Tsai C, Hung C, et al.
Ann Surg Open
. 2023 Aug;
3(4):e224.
PMID: 37600289
Methods: A total of 43 patients with treatment-naïve GISTs who had undergone surgical resections were enrolled, on whom a metabolomics profile detected from surgical specimens was constructed based on the...